Dyadic International, Inc. (DYAI)
Largest Insider Buys in Sector
DYAI Stock Price History Chart
DYAI Stock Performance
About Dyadic International, Inc.
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vaccines and drugs, such as virus like particles and antigens, monoclonal antibodies, bi/tri-specific antibodies, fab antibody fragments, Fc-fusion proteins, biosimilars and/or biobetters, and other therapeutic enzymes and proteins. It offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial, is to validate to serve as proof of concept for the development of next generation multivariant COVID-19 vaccine candidates. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; strategic research services agreement with Biotechnology Developments for Industry in Pharmaceuticals, S.L.U.; and collaboration with Syngene International Limited. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.
Insider Activity of Dyadic International, Inc.
Over the last 12 months, insiders at Dyadic International, Inc. have bought $0 and sold $0 worth of Dyadic International, Inc. stock.
On average, over the past 5 years, insiders at Dyadic International, Inc. have bought $100,266 and sold $548,927 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,670 shares for transaction amount of $16,812 was made by Rawson Ping Wang (Chief Financial Officer) on 2021‑06‑03.
List of Insider Buy and Sell Transactions, Dyadic International, Inc.
| 2022-07-07 | Sale | TCHELET RONEN | VP of Research and Bus. Dvlpmt | 1,089 0.0038% | $3.41 | $3,713 | -45.59% | |
| 2021-12-23 | Sale | EMALFARB MARK A | President and CEO | 28,767 0.1022% | $4.10 | $117,945 | -35.64% | |
| 2021-12-22 | Sale | EMALFARB MARK A | President and CEO | 35,649 0.1276% | $4.12 | $146,874 | -35.37% | |
| 2021-12-21 | Sale | EMALFARB MARK A | President and CEO | 26,486 0.0937% | $4.33 | $114,684 | -39.22% | |
| 2021-06-09 | Sale | EMALFARB MARK A | President and CEO | 23,000 0.0839% | $3.72 | $85,560 | +1.08% | |
| 2021-06-08 | Sale | EMALFARB MARK A | President and CEO | 30,000 0.1074% | $3.82 | $114,600 | -3.37% | |
| 2021-06-07 | Sale | EMALFARB MARK A | President and CEO | 44,000 0.1604% | $3.95 | $173,800 | -4.59% | |
| 2021-06-04 | Sale | EMALFARB MARK A | President and CEO | 132,000 0.48% | $3.85 | $508,200 | -2.22% | |
| 2021-06-03 | Sale | EMALFARB MARK A | President and CEO | 26,721 0.0969% | $3.61 | $96,463 | +4.17% | |
| 2021-06-03 | Rawson Ping Wang | Chief Financial Officer | 4,670 0.0169% | $3.60 | $16,812 | +4.17% | ||
| 2021-06-02 | Sale | EMALFARB MARK A | President and CEO | 76,349 0.2814% | $3.74 | $285,545 | +2.18% | |
| 2021-06-02 | Rawson Ping Wang | Chief Financial Officer | 22,330 0.0823% | $3.74 | $83,454 | +2.18% | ||
| 2019-12-11 | Sale | TCHELET RONEN | VP of Research and Bus. Dvlpmt | 4,575 0.0167% | $5.80 | $26,535 | +8.48% | |
| 2019-12-10 | Sale | TCHELET RONEN | VP of Research and Bus. Dvlpmt | 5,425 0.0201% | $5.84 | $31,682 | +9.23% | |
| 2019-12-03 | Sale | Buckland Barry | director | 15,000 0.0546% | $6.18 | $92,700 | +1.13% | |
| 2019-11-11 | Sale | TCHELET RONEN | VP of Research and Bus. Dvlpmt | 10,000 0.0366% | $5.99 | $59,900 | +3.69% | |
| 2019-10-11 | Sale | TCHELET RONEN | VP of Research and Bus. Dvlpmt | 10,436 0.0356% | $6.08 | $63,451 | -6.00% | |
| 2019-10-10 | Sale | TCHELET RONEN | VP of Research and Bus. Dvlpmt | 9,564 0.0219% | $3.73 | $35,626 | +3.12% | |
| 2019-09-10 | Sale | TCHELET RONEN | VP of Research and Bus. Dvlpmt | 20,000 0.0463% | $3.34 | $66,800 | +14.12% | |
| 2019-08-13 | Sale | TCHELET RONEN | VP of Research and Bus. Dvlpmt | 12,600 0.0437% | $5.75 | $72,450 | -1.31% |
Insider Historical Profitability
| EMALFARB MARK A | President and CEO | 4244015 14.7305% | $1.70 | 0 | 9 | |
| KITT BARRY M | 10 percent owner | 1959172 6.8001% | $1.70 | 12 | 0 | |
| WARNER STEPHEN J | director | 274800 0.9538% | $1.70 | 0 | 6 | |
| Rawson Ping Wang | Chief Financial Officer | 35850 0.1244% | $1.70 | 2 | 0 | +3.17% |
| TCHELET RONEN | VP of Research and Bus. Dvlpmt | 0 0% | $1.70 | 0 | 12 | |
| Buckland Barry | director | 0 0% | $1.70 | 0 | 1 |
Institutional Investor Ownership
| Bandera Partners LLC | $2.62M | 5.36 | 1.57M | 0% | +$0 | 1.1 | |
| Chapin Davis Inc | $1.38M | 2.83 | 826,301 | 0% | +$0 | 0.51 | |
| The Vanguard Group | $1.34M | 2.75 | 804,038 | +0.01% | +$202.07 | <0.0001 | |
| NORTHEAST FINANCIAL CONSULTANTS, INC | $417,500.00 | 0.86 | 250,000 | 0% | +$0 | 0.02 | |
| BlackRock | $413,262.00 | 0.85 | 247,462 | -0.46% | -$1,923.84 | <0.0001 | |
| Geode Capital Management | $374,820.00 | 0.77 | 224,391 | +0.76% | +$2,831.31 | <0.0001 | |
| Sage Mountain Advisors | $177,962.00 | 0.36 | 106,564 | 0% | +$0 | 0.02 | |
| Northern Trust | $129,584.00 | 0.27 | 77,595 | +0.62% | +$801.60 | <0.0001 | |
| Hightower Advisors | $129,000.00 | 0.26 | 77,319 | New | +$129,000.00 | <0.0001 | |
| Perkins Capital Management Inc | $80,000.00 | 0.16 | 47,850 | 0% | +$0 | 0.07 | |
| Pekin Singer Strauss Asset Management Il | $78,523.00 | 0.16 | 47,020 | 0% | +$0 | 0.01 | |
| State Street | $72,729.00 | 0.15 | 43,550 | -22.99% | -$21,710.15 | <0.0001 | |
| Callan Capital | $45,381.00 | 0.09 | 27,174 | New | +$45,381.00 | <0.01 | |
| Susquehanna International Group | $42,659.00 | 0.09 | 25,544 | -47.47% | -$38,547.41 | <0.0001 | |
| AE Wealth Management LLC | $31,897.00 | 0.07 | 19,100 | +19.7% | +$5,250.48 | <0.0001 | |
| Renaissance Technologies | $28,000.00 | 0.06 | 16,900 | +9.74% | +$2,485.21 | <0.0001 | |
| Charles Schwab | $27,281.00 | 0.06 | 16,336 | 0% | +$0 | <0.0001 | |
| CAPTRUST | $25,050.00 | 0.05 | 15,000 | 0% | +$0 | <0.0001 | |
| Sabal Trust Company | $18,555.00 | 0.04 | 11,111 | 0% | +$0 | <0.01 | |
| Hoey Investments Inc | $16,445.00 | 0.03 | 9,847 | New | +$16,445.00 | <0.01 | |
| Citadel Advisors LLC | $15,949.00 | 0.03 | 9,550 | -78.49% | -$58,184.62 | <0.0001 | |
| Tower Research Capital | $9,095.00 | 0.02 | 5,446 | -5.21% | -$499.34 | <0.0001 | |
| PNC Financial Services | $7,515.00 | 0.02 | 4,500 | +12.5% | +$835.00 | <0.0001 | |
| Royal Bank of Canada | $7,000.00 | 0.01 | 4,236 | -1.47% | -$104.11 | <0.0001 | |
| Riggs Asset Managment Co Inc | $1,670.00 | <0.01 | 1,000 | -33.33% | -$835.00 | <0.01 | |
| Morgan Stanley | $758.00 | <0.01 | 454 | 0% | +$0 | <0.0001 | |
| Fidelity Investments | $251.00 | <0.01 | 150 | New | +$251.00 | <0.0001 | |
| Wells Fargo | $561.00 | <0.01 | 336 | +0.9% | +$5.01 | <0.0001 | |
| Group One Trading | $344.00 | <0.01 | 206 | New | +$344.00 | <0.0001 | |
| JPMorgan Chase | $48.00 | <0.01 | 29 | 0% | +$0 | <0.0001 | |
| Barclays | $0 | <0.01 | 72 | 0% | +$0 | <0.0001 |